Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
45.75
-1.02 (-2.18%)
At close: Dec 5, 2025, 4:00 PM EST
45.66
-0.09 (-0.20%)
After-hours: Dec 5, 2025, 7:38 PM EST
Harrow Revenue
Harrow had revenue of $71.64M in the quarter ending September 30, 2025, with 45.44% growth. This brings the company's revenue in the last twelve months to $250.04M, up 47.83% year-over-year. In the year 2024, Harrow had annual revenue of $199.61M with 53.32% growth.
Revenue (ttm)
$250.04M
Revenue Growth
+47.83%
P/S Ratio
6.66
Revenue / Employee
$654,560
Employees
382
Market Cap
1.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 199.61M | 69.42M | 53.32% |
| Dec 31, 2023 | 130.19M | 41.60M | 46.95% |
| Dec 31, 2022 | 88.60M | 16.12M | 22.24% |
| Dec 31, 2021 | 72.48M | 23.61M | 48.30% |
| Dec 31, 2020 | 48.87M | -2.29M | -4.48% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
HROW News
- 8 days ago - Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45% - The Motley Fool
- 12 days ago - Harrow to Present at Two Investor Conferences in December - GlobeNewsWire
- 18 days ago - Harrow Announces Closing of Acquisition of Melt Pharmaceuticals - GlobeNewsWire
- 24 days ago - Harrow, Inc. (HROW) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Harrow Announces Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Harrow Q3 Earnings Preview: This Business Has Eye-Popping Potential - Seeking Alpha
- 5 weeks ago - Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025 - GlobeNewsWire
- 7 weeks ago - Harrow: Positive And Negative Adjustments After Investor Day Offset Each Other - Seeking Alpha